Document:

EXHIBIT 10.1
                              FORM OF AWARD LETTER

[date]

[Participant Name]
[Address]
[City, State  Zip]

RE:  1997 Long-Term Incentive Plan Performance Award and Targets for
     Six Month Period ending May 31, 2008

Dear Participant:

     The  Compensation  Committee  of the  Board  of  Directors  of  Worthington
Industries,  Inc. (the  "Company") has granted to you a Performance  Bonus Award
under the  Company's  1997  Long-Term  Incentive  Plan (the "Plan") on the terms
described  below. The Performance  Bonus Award is designed to provide  incentive
payouts to certain senior  managers based on the attainment of stated  financial
performance  targets  over  the  six-month  period  ending  May  31,  2008  (the
"Performance Period").

     In an effort to focus on both the  quantity  and quality of  earnings,  the
Performance  Bonus Awards  incorporate both an earnings and economic value added
("EVA")  component.  The  Performance  Bonus  Award and the  targets are for the
six-month  performance period ending May 31, 2008. For corporate officers,  half
of the possible  Performance Bonus Award is allocated to the corporate  earnings
per share ("EPS") target and half to the corporate EVA target. For business unit
executives, the Performance Bonus Award is structured a little differently:  20%
of the possible  Performance  Bonus Award is allocated to the same corporate EPS
targets as the corporate  officers,  30% is allocated to business unit operating
income targets, and 50% is allocated to business unit EVA targets.

     Your Performance Bonus Award for the Performance Period ending May 31, 2008
and specific performance targets are set forth below:

    ---------------------------------------------------------------------------
     Corporate EPS Targets        Corporate EPS* Targets           Cash Award
    ---------------------------------------------------------------------------
    ---------------------------------------------------------------------------
      Threshold                       $__________                  $__________
    ---------------------------------------------------------------------------
      Target                          $__________                  $__________
    ---------------------------------------------------------------------------
      Maximum                         $__________                  $__________
    ---------------------------------------------------------------------------
    ---------------------------------------------------------------------------

                                       7
<PAGE>

    ---------------------------------------------------------------------------
     Corporate EVA Targets        Corporate EVA* Targets           Cash Award
    ---------------------------------------------------------------------------
    ---------------------------------------------------------------------------
      Threshold                       $__________                  $__________
    ---------------------------------------------------------------------------
      Target                          $__________                  $__________
    ---------------------------------------------------------------------------
      Maximum                         $__________                  $__________
    ---------------------------------------------------------------------------
    ---------------------------------------------------------------------------

* Targets  are for the  six-month  period  ending  May 31,  2008.  Restructuring
charges and other unusual or non-recurring  items will be excluded as determined
in the discretion of the Compensation Committee.

    ---------------------------------------------------------------------------
     Business Unit __________         Business Unit**
     EVA Targets                        EVA Targets                Cash Award
    ---------------------------------------------------------------------------
    ---------------------------------------------------------------------------
      Threshold                       $__________ Million          $__________
    ---------------------------------------------------------------------------
      Target                          $__________ Million          $__________
    ---------------------------------------------------------------------------
      Maximum                         $__________ Million          $__________
    ---------------------------------------------------------------------------
    ---------------------------------------------------------------------------

    ---------------------------------------------------------------------------
     Business Unit __________         Business Unit**
     EOI Targets                        EOI Targets                Cash Award
    ---------------------------------------------------------------------------
    ---------------------------------------------------------------------------
      Threshold                       $__________ Million          $__________
    ---------------------------------------------------------------------------
      Target                          $__________ Million          $__________
    ---------------------------------------------------------------------------
      Maximum                         $__________ Million          $__________
    ---------------------------------------------------------------------------
    ---------------------------------------------------------------------------

** Targets are for the  six-month  period  ending May 31,  2008.  Business  unit
results shall be calculated  excluding  corporate  allocations  not under direct
control of the  business  unit and  restructuring  changes and other  unusual or
non-recurring  items,  as  determined  in the  discretion  of  the  Compensation
Committee.

     Performance  falling  between  threshold  and target or between  target and
maximum will be pro rated on a linear basis.

     No payments will be made if performance falls below threshold.  Each of the
performance  measures is free standing so that you will be able to earn a payout
based upon the  achievement  of one measure,  even if the threshold  performance
level is not achieved in the other measure.

     Calculation of the Company  results and attainment of performance  measures
will be made  solely by the  Compensation  Committee  based  upon the  Company's
consolidated  financial statements.  The Compensation Committee has the right to
make changes and  adjustments in calculating  the  performance  measures to take
into account unusual or non-recurring  events,  including,  without  limitation,
changes in tax and accounting  rules and  regulations;  extraordinary  gains and
losses;  mergers and acquisitions and purchases or sales of substantial  assets;
provided  that,  if  Section  162(m)  of the  Internal  Revenue  Code  would  be
applicable to the pay-out of the Performance  Awards hereunder,  any such change
or adjustment must be permissible under Section 162(m).

                                       8
<PAGE>

     The  determination  of the  attainment of  performance  objectives  and the
amount of the  Performance  Bonus  Awards  payable  will  generally be finalized
within a reasonable time after the applicable  consolidated financial statements
of the  Company  has  been  completed.  Payments  will  then  be made  within  a
reasonable time after finalization by the Committee,  unless there is a need for
a delay.

     Unless the Committee  elects a different  form of payout,  payments will be
made in cash.  The Committee may adopt  provisions  permitting the deferral of a
portion or all of the payout into a Deferred  Compensation Plan, provided that a
timely  deferral  election is made.  The Company may require  payment of, or may
withhold from payments,  amounts  necessary to meet any federal,  state or local
tax withholding requirements.

     In  general,  termination  of  employment  terminates  Performance  Awards.
Termination  of employment for reasons of death,  disability or retirement  will
result  in a  pro  rata  payout  for  the  Performance  Period.  Termination  of
employment for any other reason,  voluntary or involuntary,  prior to the end of
the Performance  Period will result in the forfeiture of the  Performance  Bonus
Award.  Upon a change of control of the Company,  all  Performance  Bonus Awards
will be  considered  earned and  payable  at  "Target"  and will be  immediately
settled.

     The provisions of the Plan are incorporated  herein by reference and a copy
is available at your request.

     If you have any questions about your Performance Bonus Awards,  please call
_________________.

Very truly yours,

                                       9Exhibit 10.1

THE COMMON STOCK  ISSUABLE  PURSUANT TO THIS  AGREEMENT HAS NOT BEEN  REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED,  OR ANY STATE  SECURITIES LAW. THE
COMMON STOCK ISSUABLE  PURSUANT TO THIS  AGREEMENT MAY NOT BE SOLD,  OFFERED FOR
SALE,  PLEDGED OR  HYPOTHECATED  IN THE ABSENCE OF A  REGISTRATION  STATEMENT IN
EFFECT UNDER SUCH ACT AND SUCH LAWS WITH  RESPECT TO THE COMMON  STOCK  ISSUABLE
PURSUANT TO THIS AGREEMENT, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY
THAT SUCH REGISTRATION IS NOT REQUIRED.

                              CAVIT SCIENCES, INC.
                         COMMON STOCK PURCHASE AGREEMENT

INFORMATION REGARDING CAVIT SCIENCES, INC., INCLUDING ITS PROSPECTUS,  FORM 10SB
REGISTRATION AND RELATED FILINGS UNDER THE SECURITIES ACTS OF 1933 AND 1934, ARE
AVAILABLE FOR REVIEW ON THE SEC'S WEBSITE ( WWW.SEC.GOV ) AND ON CAVIT SCIENCES,
INC.'S WEBSITE (WWW.CAVITSCIENCES.COM ).

     This COMMON STOCK PURCHASE AGREEMENT ("Agreement") is made this 29th day of
November  2007 by and  between  CAVIT  SCIENCES,  INC.,  a  Florida  corporation
("CAVIT" or the "Company"), and Vision International Enterprises, S.A. ("Vision"
or "Investor").

                                   Background

     As more fully set forth  herein,  Investor has agreed to purchase  from
the Company  shares of Common  Stock  ("Common  Stock") and  warrants for common
stock ("Warrants") for a purchase price of $250,000. ("Commitment Amount").
Agreement

     NOW, THEREFORE,  intending to be legally bound hereby, the parties agree as
follows:

     1. Commitment.  Subject to the terms and conditions hereof, Investor agrees
to purchase  1,250,000  shares of Cavit's  Common Stock from Cavit at a purchase
price of $.20 per share and  1,500,000  warrants  for  Cavit's  Common  Stock at
strike  prices  ranging  from $.40 to $3.00 per share  (see  table  below)  with
varying   expiration   dates  (see  table  below)  from  the  date  of  issuance
("Commitment Purchase Amount") not to exceed the Commitment Amount.

TABLE: The number of warrants, class of warrants, exercise price of warrants and
term of warrants are set forth below:

     Class    No. of Warrants          Exercise Price             Term
     -----    ---------------          --------------             ----

       A          125,000             $ .40 per share           6 months
       B          125,000             $ .60 per share           9 months
       C          125,000             $ .80 per share          12 months
       D          175,000             $1.00 per share          15 months
       E          175,000             $1.25 per share          18 months
       F          175,000             $1.50 per share          21 months
       G          175,000             $1.75 per share          24 months
       H          250,000             $2.00 per share          36 months
       I          175,000             $3.00 per share          48 months

     2. Share  Issuance.  Upon the payment of the  Commitment  Purchase Price as
aforesaid, the Company shall issue and cause to be delivered with all reasonable
dispatch to Investor and in the name of Investor,  a certificate or certificates
for the  number of shares of Common  Stock so  purchased.  Such  certificate  or
certificates shall be deemed to have been issued and Investor shall be deemed to
have become a holder of record of such Common Stock on and as of the date of the
delivery  to the  Company of and  payment of the  Commitment  Purchase  Price as
aforesaid.  If,  however,  at the date of  payment of such  Commitment  Purchase
Price, the transfer books for the Common Stock shall be closed, the certificates
for the Common Stock shall be issued and Investor shall become a record owner of
such  Common  Stock on and as of the  next  date on which  such  books  shall be
opened,  and until such date the  Company  shall be under no duty to deliver any
certificate for such Common Stock.
<PAGE>
       3. Warrant Issuance. Upon the payment of the Commitment Purchase Price as
aforesaid, the Company shall issue and cause to be delivered with all reasonable
dispatch to Investor  and in the name of  Investor,  warrants  for the number of
warrants for Common Stock so purchased.  Such  warrants  shall be deemed to have
been  issued and  Investor  shall be deemed to have become a holder of record of
such  warrants  on and as of the  date of the  delivery  to the  Company  of and
payment of the Commitment Purchase Price as aforesaid.

     4.  Representations  by Investor.  Investor  represents and warrants to the
     Company as follows:

     a) Investor has relied only upon the information presented and contained in
     the Term Sheet  provided  by the  Company  ("Offering  Materials")  and the
     INVESTOR  HAS  READ  AND  UNDERSTANDS  THE  INFORMATION  CONTAINED  IN  THE
     COMPANY'S PROSPECTUS, FORM 10 SB REGISTRATION AND RELATED FILINGS UNDER THE
     SECURITIES ACTS OF 1933 AND 1934,  WHICH ARE AVAILABLE ON THE SEC'S WEBSITE
     REFERRED TO ABOVE. Investor has had the opportunity to ask of the person or
     persons  acting on behalf of the Company any and all relevant  questions in
     connection  with any aspect of the Company  including,  but not limited to,
     the Common Stock offered by the Offering Materials and has received answers
     which  Investor  considers to be reasonably  responsive to such  questions.
     Investor has had the  opportunity to verify the accuracy of the information
     contained in the Offering Materials.

     (b) Investor  understands that Investor is subscribing for the Common Stock
     without  being  furnished any  literature  in connection  with the Offering
     other than the  Offering  Materials,  and that the  Offering  of the Common
     Stock presented in the Offering Materials will not have been scrutinized by
     the Securities and Exchange  Commission or by the securities  administrator
     or  similar  bureau,  agency,  or  department  of the state of  Investor's'
     residence.

     (c) Investor  understands (i) that the Common Stock has not been registered
     under the  Securities  Act of 1933,  as amended  ("Act"),  or registered or
     qualified under the securities laws of the state of Investor's'  residence,
     (ii) REGISTRATION RIGHTS: upon receipt of a written demand by the Investor,
     the  Company  is  obligated  to  register  the  shares of Common  Stock and
     warrants  under the  Securities  Act of 1933, as amended,  within limits of
     current SEC guidelines.

     (d) The Common  Stock is being  purchased  for  Investor's  own account for
     investment  purposes  only and not for the interest of any other person and
     is not  being  purchased  with a view to or for the  resale,  distribution,
     subdivision or fractionalization thereof.

     (e) Investor is able to bear the economic  risks related to purchase of the
     Common Stock for an  indefinite  period of time (i.e.,  Investor is able to
     afford a complete  loss of the Common  Stock  Investor  is  subscribing  to
     purchase).  Investor's  net  worth  and  assets  are  sufficient  to enable
     Investor to purchase shares of Common Stock from Cavit in the amount of the
     Commitment Amount pursuant to this Agreement.

     (f)  Investor's  overall  commitment to  investments  which are not readily
     marketable is not  disproportionate  to Investor's net worth and Investor's
     investment in the Company will not cause such overall  commitment to become
     excessive.

     (g) Investor has adequate means of providing for  Investor's  current needs
     and possible personal contingencies.  Investor has no need for liquidity of
     the Common Stock  subscribed  to be  purchased  hereby and has no reason to
     anticipate any change in Investor's  personal  circumstances,  financial or
     otherwise,  which might cause or require any sale or  distribution  of such
     Common Stock subscribed to be purchased.

     (h) Investor  recognizes  that the purchase of the Common Stock  involves a
     high degree of risk including those special risks.

     (i) Investor understands that Investor's right to transfer the Common Stock
     will be restricted as set forth on the  certificate  evidencing  the Common
     Stock. Such restrictions  include  provisions  against transfer unless such
     transfer is not in violation  of the Act, or  applicable  state  securities
     laws (including investor suitability standards).

                                       2
<PAGE>
     (j) All information  which Investor has provided to the Company  including,
     but not  limited  to,  financial  position,  and  status  as an  accredited
     investor,  and knowledge of financial and business matters is true, correct
     and  complete  as of the  date of  execution  of this  Agreement.  Investor
     understands  that the  Company  will  rely in a  material  degree  upon the
     representations contained herein.

     (k)  Investor  understands  that a  legend  may  be  placed  on  any  stock
     certificate  representing  the Common Stock  substantially to the following
     effect:

     On the front side:

     "Transfer of the shares represented by this certificate is restricted - see
     reverse side."

     On the reverse side:

     "The  shares  represented  by this  certificate  have  been  issued  to the
     registered owner in reliance upon written representations that these shares
     have been taken for investment. These shares have not been registered under
     the  Securities  Act of  1933,  as  amended  ("Act"),  and may not be sold,
     transferred or assigned  unless an opinion of counsel  satisfactory  to the
     company  has been  received  by the  company to the effect  that such sale,
     transfer or  assignment  will not be in  violation of the Act and the rules
     and  regulations  promulgated  thereunder  or applicable  state  securities
     laws."

     (l) Investor is an "accredited investor" as defined in Rule 501 promulgated
     under the Act because Investor's  individual net worth (or Investor's joint
     net worth with his spouse) on the date hereof exceeds $1,000,000.

     5.  Securities  Laws.  As a condition  to the  issuance of any Common Stock
pursuant   this   Agreement,   Investor   shall   execute   and   deliver   such
representations,  warranties,  and covenants, that may be required by applicable
federal and state  securities law, or that the Company  determines is reasonably
necessary in connection with the issuance of such Common Stock. In addition, the
certificates  representing  the Common  Stock shall  contain  such  legends,  or
restrictive  legends,  or stop  transfer  instructions,  as shall be required by
applicable Federal or state securities laws, or as shall be reasonably  required
by the Company or its transfer  agent.  The Investor has completed and delivered
an Investor Questionnaire to the Company.

     6.  Binding  Effect.  This  Agreement  shall be  binding  upon the  party's
respective heirs, personal  representatives,  successors and assigns;  provided,
however, that this Agreement shall not be assignable by Investor, in whole or in
part, without the prior consent of the Company.

     7.  Applicable  Law. This  Agreement  shall be deemed to be a contract made
under the laws of the State of Florida and for all  purposes  shall be construed
in accordance with the laws thereof regardless of its choice of law rules.

     8. Brokers and Finders.  Cavit and Investor hereby  represent to each other
that no broker or  finder  has been  employed  or  engaged  by either of them in
connection  with the  transactions  contemplated  in this Agreement and that all
negotiations  relative to this Agreement  have been carried on directly  between
the parties hereto without the intervention of any other person.

     9.  Survival  of  Representations   and  Warranties,   and  Remedies.   All
representations  and warranties  contained in this  Agreement  shall survive the
execution and delivery of this Agreement.

     10. Entire Agreement.  This Agreement  constitutes the entire understanding
and  agreement  between the  parties  hereto  with  respect to the  transactions
contemplated  herein,  supersedes  all  prior  and  contemporaneous  agreements,
understandings,  negotiations and discussions,  whether oral or written,  of the
parties, and there have been no warranties, representations or promises, written
or oral, made by any of the parties hereto except as herein  expressly set forth
herein.

     11. Waiver, Modification, etc. Any party to this Agreement may waive any of
the  terms  or  conditions  of  this  Agreement  or  agree  to an  amendment  or
modification  to this Agreement by an agreement in writing  executed in the same
manner (but not necessarily by the same persons) as this Agreement. No amendment
or modification of this Agreement shall be binding unless in writing executed by
all of the parties to this Agreement. No waiver of any of the provisions of this
Agreement  shall be deemed or shall  constitute a waiver of any other  provision
hereof  (whether or not similar),  nor shall any waiver  constitute a continuing
waiver unless otherwise expressly provided.

                                       3
<PAGE>
     12.  Funding Date. It is the intention of the Investor to begin funding the
Commitment Purchase Price on or before November 30, 2007.

     13.  Notice.  Any  notice or other  communications  required  or  permitted
hereunder shall be sufficiently given: (i) three (3) business days after if sent
by certified mail, return receipt  requested,  postage prepaid,  or (ii) one (1)
business day after sent by Federal Express or other overnight  courier providing
delivery  confirmation for next business day delivery, or (ii) when delivered by
personal delivery, telecopier, or e-mail, in any event delivered to or addressed
as follows:

     If to Investor:

           Vision International Enterprises, S.A.
           522 Balboa Plaza
           Balboa Avenue, Panama
           Attn: Sara L. de Nunez, President

     If to Cavit:

           Cavit Sciences, Inc.
           100 E. Linton Blvd., Suite 106B
           Delray Beach, Florida 33483
           Attention: Colm J. King, CEO

     14. Counterparts.  This Agreement may be signed in two or more counterparts
which counterparts shall constitute a single,  integrated agreement binding upon
all the signatories to such counterparts. Delivery of an executed counterpart of
this  Agreement  by  facsimile  shall be equally as  effective  as delivery of a
manually executed counterpart of this Agreement.

     15. Expenses.  Except as specifically provided otherwise herein, each party
hereto shall pay its or his own expenses  arising  from this  Agreement  and the
transactions contemplated hereby, including,  without limitation,  all legal and
accounting fees and disbursements;  provided, however, that nothing herein shall
limit or  otherwise  modify any right of the  parties to recover  such  expenses
(including  legal fees and costs of litigation)  from the other in the event any
party hereto breaches this Agreement.

     16. Further Assurances.  Each of the parties hereto shall hereafter execute
and deliver such further  documents and instruments and do such further acts and
things as may be  required or useful to carry out the intent and purpose of this
Agreement and as are not inconsistent with the terms hereof.

     IN WITNESS  WHEREOF,  the parties  hereto have executed and delivered  this
Common Stock Purchase Agreement on the date first written above.

Vision International Enterprises, S.A.          Cavit Sciences, Inc.

By: /s/ Sara L. de Nunez                        By: /s/ Colm J. King
   -----------------------------                   -----------------------------
Sara L. de Nunez                                Colm J. King,
Title: President                                Title: Chief Executive Officer

                                       4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}]]